Innovative Medicines
Our focus is to develop and deliver Innovative Medicines that address unmet medical needs and improve the standard of care for our patients.
Sun Pharma Canada Inc. has invested heavily to expand its Innovative Medicines product portfolio, advance a robust pipeline of clinical-stage assets and identify key partnership opportunities to support continued growth.
Sun Pharma Canada Inc.’s portfolio of Innovative Medicines offers targeted treatment options trusted by both healthcare professionals and patients.
Sun Pharma dedicates approximately 10% of its annual Innovative Medicines revenue toward R&D of Innovative Medicines.
Therapeutic Areas
At Sun Pharma Canada Inc., we are driven by promising science that has the potential to transform the lives of patients and families across Canada. As we continue to expand our product portfolio and clinical pipeline, we actively seek innovative partnerships that complement our expertise and accelerate the development of medicines in these key focus areas:
Dermatology/I&I (Immunology & Inflammation)
- Plaque Psoriasis (IL-23 inhibitor)
- Acne
Ophthalmology
- Dry Eye
Oncology
- Actinic Keratosis
- Locally Advanced Basal Cell Carcinoma
Clinical Trials
Sun Pharma is committed to advancing medical research through clinical trials, offering eligible patients access to investigational treatments. Participants must meet study-specific criteria.
Contact us at [email protected] or call 1-833-388-0532 to explore available clinical trials. Your participation could make a difference.
Collaborate with us
Partnering with Sun Pharma Canada Inc. means joining forces with a global pharmaceutical leader committed to investing in innovation and delivering impactful treatments for people in Canada and around the world. Our investments in advancing our Canadian Innovative Medicines portfolio revolve around three core strategies:
- Strategic partnerships: We aim to expand our emerging product portfolio by securing access through in-licensing agreements and strategic acquisitions.
- Clinical development: We are committed to advancing our pipeline of Innovative Medicine assets through rigorous clinical development, leveraging Sun Pharma’s in-house R&D capabilities and established relationships with external third-parties.
- Commercial infrastructure: We have established a robust commercial infrastructure to market and distribute our Innovative Medicines, Generics and Consumer Healthcare products effectively.
Become a Sun Pharma partner today
Contact us if you are interested in partnering with Sun Pharma Canada Inc. Together, we can advance new treatments and meaningfully impact patients’ lives.
For more information about collaborating with us in Canada, please contact our Business Development team lead: Atul Raut, Sun Pharma, VP Business Development [email protected]
For more information about partnering with us in the U.S. or EU, please contact our Business Development team lead: Pankaj Gupta, Sun Pharma, VP Business Development [email protected]
Center of Excellence
Sun Pharma’s Centre of Excellence (CoE) plays a critical role in driving innovation, ensuring cost efficiency, and accelerating drug development—benefiting millions of Canadian patients and healthcare providers. With more than 40 years of history as a pharmaceutical leader in India, Sun Pharma is uniquely positioned to take full advantage of the CoE.
- Global expertise, local execution. India CoE supports drug development projects through India hub, ensuring seamless integration with global operations.
- Innovation hub. India CoE serves as an innovation hub, combining the latest developments in pharmaceutical research with India’s rich scientific talent pool to drive breakthroughs in drug discovery and development.
- Cost efficiency. India CoE offers significant cost advantages without compromising quality, enabling Sun Pharma to optimize resources.